Official UK procurement notice
Contract for the provision of pathology diagnostic testing and reporting
Authority: Great Western Hospitals NHS Foundation Trust (Central government)
What is being bought
Published requirement descriptionA contract for the provision of pathology diagnostic testing and reporting services for a period of one year, with an option to extend for a further period of one year.
CPV: Pathology services
The lotProcurement structure
single lot · no lot value publishedLot #1A direct award to UHS for the supply of pathology diagnostic testing and reporting…
A direct award to UHS for the supply of pathology diagnostic testing and reporting services
Procedure terms & legal framework
From the official record- Procedure method
- Award procedure without prior publication of a call for competition
- Legal basis
- CELEX · 32014L0024 Public Contracts Regulations 2015 (Directive 2014/24/EU)
- Procurement category
- Services
- Notice status
- Awarded without competition
- Procurement threshold
- Unspecified in notice
- Regulatory regime
- Standard
- Commercial structure
- Stand-alone contract (no framework)
- Competition type
- Direct award (no call for competition)
- GPA / WTO covered
- Unspecified in notice
- Recurring procurement
- Unspecified in notice
- First published
- 14 Feb 2023, 12:27 GMT
- Last source update
- 14 Feb 2023, 12:27 GMT
- FTS notice number
2023/S 000-004486- Classification (CPV)
- Delivery area
- Official registry OCID
ocds-h6vhtk-03a57bFind a Tender
- Why no open competition
- The procurement falls outside the scope of application of the directive
- Published justification
Great Western Hospitals NHS Foundation Trust (GWH) intends to award a contract under Regulation 32(2)(b)(ii), to University Hospital Southampton NHS Foundation Trust (UHS) in respect of pathology referral testing and reporting, for a period of one year, with an option to extend for a further period of one year. This to maintain a continuation of service delivery, until the requirement is transitioned into the South 4 Pathology Partnership Trust (S4PP) network. This will be undertaken on completion of the network’s LIMs IT integration project, which has experienced delay during implementation but is now scheduled to “GoLive” in April 2024. UHS is the incumbent supplier and the new contract, whilst transition to S4PP is ongoing, will ensure that the current service is maintained until the described period of transition is complete, without potential risk to patient care and accumulating both cost and resource pressures. To engage another supplier for a temporary arrangement of this nature may result in the following:<br/>
- A detrimental effect on patient care. Laboratory users in GWH will lose the continuity of analysis of tests being performed by the same laboratory. A shift in reference ranges (depending on the analytical platform used) may result in laboratory users having to allow for a change in analytical references when interpreting results, adding a layer of variation and complication in a series of their patient results.<br/>
- IT system set-up. GWH relies on NPEX to send samples and receive reports back electronically. A temporary connection would need to be established with a new provider, resulting in the need for both IT and laboratory additional resource and subsequent cost. If manual (typed) reporting is required during set-up, additional staff will need to be recruited while an IT connection is established.<br/>
- Documents within the laboratory will need to be re-written to incorporate a new supplier, which will require additional resource.<br/>
- Packaging and transport will need reviewing and changing to accommodate any new supplier. This will result in additional resource to conduct the review and potentially additional cost to purchase suitable packaging.<br/>
- Turnaround times (TATs) may vary while a new supplier is established. UHS TATs to GWH are both established and consistent, and users use this information to arrange subsequent clinics and consultations accordingly. <br/>
- As a result of a review of the elements outlined above, GWH considers that for technical reasons described above, awarding UHS is the only reasonable solution to as it mitigates the risk of a detrimental effect on the service and an accumulation of preventable cost and resource pressures. <br/>GWH will observe a 10 day standstill period from the date of this notice before entering into a contract with UHS.
Commercial outcome & contract awards
Published awards, contracts and bid statistics, not a forecast| Awarded to | Value | Date | Status |
|---|---|---|---|
| University Hospital Southampton NHS Foundation Trust | £1,320,000 † | — | Awarded |
Contracts
Contract 004486-2023-1 · University Hospital Southampton NHS Foundation Trust
- Signed
- 10 Feb 2023
- Value
- £1,320,000
- Status
- active
Contracting authority & participating public bodies
Dispute resolution & review bodies
- Salisbury Managed Procurement ServicesReview bodyReview contact point
Bidders & participating suppliers
1 commercial party on the notice- University Hospital Southampton NHS Foundation TrustAwarded supplier
Official documents & specifications
Official links; attachments are not copiedNo document links were published on the notice.